The company said that given recent debt restructuring efforts and certain regulatory and payor approvals of its products, it's on track for a strong 2017.
In Nucleic Acids Research this week: isomiR-based cancer classifier, map of VjbR binding in Brucella, and more.
The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.
In Science this week: DNA Fountain for storing data in DNA, and more.
The collaborators are developing tests for rectal cancer based on microRNA and messenger RNA signatures.
In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.
Investigators explored computational strategies for identifying microRNAs that are most relevant to tumor development and progression.
In PLOS this week: ramifications of multi-nucleotide de novo mutations, circulating microRNAs and atrial fibrillation, and more.
The partners aim to identify a microRNA-based signature that can predict lung cancer patient response to Bristol-Myers Squibb's immunotherapy Opdivo.
In PLOS this week: methylation in human gametes, microRNAs linked to kidney damage in lupus patients, and more.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.